Y-Biologics Employee Stock Ownership Association Completes On-Market Stock Purchase

The employee stock ownership association of Y-Biologics has completed an on-market stock purchase.

According to Y-Biologics on August 31, this is the third such purchase since the company was listed on the KOSDAQ market in December 2023. The company continues to strengthen long-term motivation for employees and executives through the employee stock ownership plan and is making ongoing efforts to enhance corporate value and practice responsible management.

In fact, major global pharmaceutical companies such as Novartis, Roche, and Sanofi operate various programs that support employee stock purchases, thereby attracting key talent and increasing corporate value. In contrast, in Korea, the employee stock ownership system has often been limited to a one-off event during the IPO, where employees are given priority allocation of public offering shares, so it has not been used as a sustained tool for motivation after the listing.

Y-Biologics is continuously expanding employee participation in stock ownership. It is unusual in Korea to provide employees with regular opportunities to acquire company shares even after listing. Currently, 65% of employees are shareholders in the company, and Y-Biologics is encouraging long-term retention by providing practical support measures such as low-interest loan programs and flexible repayment periods.

This content was produced with the assistance of AI translation services.